These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34070092)

  • 1. The Proportion Cured of Patients with Resected Stage II-III Cutaneous Melanoma in Sweden.
    Eriksson H; Utjés D; Olofsson Bagge R; Gillgren P; Isaksson K; Lapins J; Schultz IL; Lyth J; Andersson TM
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proportion cured of patients diagnosed with Stage III-IV cutaneous malignant melanoma in Sweden 1990-2007: A population-based study.
    Eriksson H; Lyth J; Andersson TM
    Int J Cancer; 2016 Jun; 138(12):2829-36. PubMed ID: 26815934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway.
    Winge-Main A; Robsahm TE; Nyakas M; Festervoll G; Torkilseng E; Thybo S; Pati S; Carroll R
    Future Oncol; 2023 Jan; 19(3):205-215. PubMed ID: 36974621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
    Vikström S; Syriopoulou E; Andersson TM; Eriksson H
    J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
    Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
    Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
    Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
    J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma.
    Kanaki T; Stang A; Gutzmer R; Zimmer L; Chorti E; Sucker A; Ugurel S; Hadaschik E; Gräger NS; Satzger I; Schadendorf D; Livingstone E
    Eur J Cancer; 2019 Sep; 119():18-29. PubMed ID: 31401470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in young and middle-aged Hodgkin lymphoma patients in Sweden 1992-2009-trends in cure proportions by clinical characteristics.
    Glimelius I; Ekberg S; Jerkeman M; Chang ET; Björkholm M; Andersson TM; Smedby KE; Eloranta S
    Am J Hematol; 2015 Dec; 90(12):1128-34. PubMed ID: 26349012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Recurrence Rates and Economic Burden in Patients with Resected Early-Stage Melanoma.
    Jang S; Poretta T; Bhagnani T; Harshaw Q; Burke M; Rao S
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):985-999. PubMed ID: 32548707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant vemurafenib in resected, BRAF
    Maio M; Lewis K; Demidov L; Mandalà M; Bondarenko I; Ascierto PA; Herbert C; Mackiewicz A; Rutkowski P; Guminski A; Goodman GR; Simmons B; Ye C; Yan Y; Schadendorf D;
    Lancet Oncol; 2018 Apr; 19(4):510-520. PubMed ID: 29477665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging system.
    Fujisawa Y; Yoshikawa S; Minagawa A; Takenouchi T; Yokota K; Uchi H; Noma N; Nakamura Y; Asai J; Kato J; Fujiwara S; Fukushima S; Uehara J; Hoashi T; Kaji T; Fujimura T; Namikawa K; Yoshioka M; Murata N; Ogata D; Matsuyama K; Hatta N; Shibayama Y; Fujiyama T; Ishikawa M; Yamada D; Kishi A; Nakamura Y; Shimiauchi T; Fujii K; Fujimoto M; Ihn H; Katoh N
    J Dermatol Sci; 2019 May; 94(2):284-289. PubMed ID: 31023613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
    Duraker N; Caynak ZC
    Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma.
    Eggermont AMM; Blank CU; Mandala M; Long GV; Atkinson VG; Dalle S; Haydon A; Lichinitser M; Khattak A; Carlino MS; Sandhu S; Larkin J; Puig S; Ascierto PA; Rutkowski P; Schadendorf D; Koornstra R; Hernandez-Aya L; Di Giacomo AM; van den Eertwegh AJ; Grob JJ; Gutzmer R; Jamal R; Lorigan PC; Lupinacci R; Krepler C; Ibrahim N; Kicinski M; Marreaud S; van Akkooi AC; Suciu S; Robert C
    Eur J Cancer; 2019 Jul; 116():148-157. PubMed ID: 31200321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and disease-specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden.
    Simberg-Danell C; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Carstensen J; Hansson J; Eriksson H
    Int J Cancer; 2016 Aug; 139(3):543-53. PubMed ID: 27004457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors.
    Barillot I; Horiot JC; Pigneux J; Schraub S; Pourquier H; Daly N; Bolla M; Rozan R
    Int J Radiat Oncol Biol Phys; 1997 Jul; 38(5):969-78. PubMed ID: 9276361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation value of preoperative peripheral blood lymphocyte-to-monocyte ratio on the prognosis of patients with stage III colon cancer].
    Chen J; Peng J; Fan W; Zhang R; Wang F; Zhou W; Xu D; Pan Z; Lu Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jan; 22(1):73-78. PubMed ID: 30703797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study.
    Lee JH; Yu M; Kim SH; Lee JH; Sung SY; Jeong BK; Jeong S; Nam TK; Jeong JU; Jang HS
    Clin Colorectal Cancer; 2019 Mar; 18(1):e130-e139. PubMed ID: 30595556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.
    Andersson TM; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Björkholm M; Dickman PW
    Br J Haematol; 2010 Mar; 148(6):918-24. PubMed ID: 19995394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified staging system for extremity soft tissue sarcomas.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 1999; 6(1):57-69. PubMed ID: 10030416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.